Weekly influenza surveillance overview, Nov 15, 2013 - week 45
During week 45/2013: All 27 reporting countries experienced low intensity influenza activity.
Weekly influenza surveillance overview, Nov 22, 2013 - week 46
During week 46/2013: All 28 reporting countries experienced low intensity influenza activity
Guide to public health measures to reduce the impact of influenza pandemics in Europe – ‘The ECDC Menu’
This document presents a menu of possible public measures to be taken during influenza pandemics, giving public health and scientific information on what is known or can be said about their likely effectiveness, costs (direct and indirect), acceptability, public expectations and other more practical considerations. The ‘ECDC Menu’ aims to help EU Member States and institutions, individually or collectively, decide which measures they will apply.
Understanding the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines
This meeting was designed to offer a place to exchange the latest information on into the development of narcolepsy following vaccination with one of the 2009 adjuvanted influenza A(H1N1) vaccines.
Report on the association between the 2009 pandemic vaccine (Pandemrix®) and narcolepsy – Republic of IrelandArchived
Investigation of an increase in the incidence of narcolepsy in children and adolescents in 2009 and 2010 - Final Report of National Narcolepsy Study Steering Committee, Department of Health, Ireland
No Serological Evidence of Influenza A H1N1pdm09 Virus Infection as a Contributing Factor in Childhood Narcolepsy after Pandemrix™ Vaccination Campaign in Finland
This is the first published study where an attempt has been made to understand the possible biological mechanisms behind development of narcolepsy following vaccination with Pandemrix™.
Factsheet about seasonal influenza
Influenza is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and sometimes the lungs. It can cause mild to severe illness, and at times can lead to death. The best way to prevent flu is by getting a flu vaccine each year.
WHO Guidance for Surveillance during an Influenza Pandemic
This guidance is an update to an earlier document “Global surveillance during an influenza pandemic”, published in April 2009. It takes the lesions learned from the 2009 influenza pandemic into consideration and focuses on the key surveillance components needed during an influenza pandemic. The purpose of the updated guidance is to outline the surveillance strategies and essential data requirements that Member States can use throughout the course of an influenza pandemic to ensure informed risk management decisions in pandemic response and fulfilment of IHR (2005) core capacity requirements.
European Commission: Influenza
Vaccination policy is a competence of national authorities however, the European Commission supports EU countries to coordinate their policies and programmes. To support EU countries in maintaining or increasing rates of vaccination, the EU Commission promotes seasonal flu vaccination to at risk groups.
WHO Europe: Influenza
WHO/Europe aim to reduce influenza-related morbidity and mortality by strengthening virological and epidemiological surveillance for mild and severe influenza; using surveillance data to estimate the burden of influenza in order to prioritize national influenza vaccination programmes; and maintaining and strengthening pandemic preparedness activities at the national level. WHO/Europe also monitors the emergence of other respiratory pathogens that have the potential to spread among humans. These include coronaviruses, which cause a range of illnesses from severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome coronavirus (MERS-CoV) to the common cold.